Our Co-Founders, Denis Grizelj and Matthew Rutledge founded MD Labs in 2011 with the goal to specialize in prescription monitoring toxicology and serve physicians across the United States. They also wanted to create a more provider-friendly testing service that prides itself on delivering prompt, accurate, reliable and easy to understand results. Employing state of the art technology and testing for a wide array of analytes, our team of PhDs and clinical technologists is able to keep ahead of the needs of our community. Constantly adding services based on client requests and pharmacotherapeutic trends allows us to provide quick, accurate, and cost-effective drug testing while enhancing patients’ prescription adherence and overall patient care. In 2014, MD Labs began offering pharmacogenetic (PGX) testing as a way for providers to better understand individual patients responses to prescription medications and reduce adverse drug reactions.